Early inhibition of mycobacterial growth by human alveolar macrophages is not due to nitric oxide

被引:58
作者
Aston, C
Rom, WN
Talbot, AT
Reibman, J
机构
[1] NYU, Med Ctr, Div Pulm & Crit Care Med, Dept Med, New York, NY 10016 USA
[2] NYU, Med Ctr, Dept Chem, New York, NY 10016 USA
关键词
D O I
10.1164/ajrccm.157.6.9705028
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Phagocytic cells provide the first line of defense against mycobacteria. We examined the relative mycobacteriostatic contributions of normal human alveolar macrophages (HAM), peripheral blood monocytes (PBM), and polymorphonuclear leukocytes (PMN) in the early time period after infection with mycobacteria (48 h). Cells were infected with Mycobacterium bovis (BCG) or M. tuberculosis H37Ra and their ability to inhibit growth was determined by mycobacterial incorporation of [H-3]uracil. HAM inhibited the growth of both mycobacteria (44.2 +/- 7.9 and 37.6 +/- 10.5% inhibition, respectively). Two populations of HAM donors were subsequently defined: inhibitors and noninhibitors. The ability to inhibit growth of H37Ra correlated with that of BCC. In contrast to HAM, PBM and PMN did not inhibit mycobacterial growth. Because nitric oxide (NO) has been proposed to mediate growth inhibition in murine models, we examined whether NO was responsible for the early growth inhibition of mycobacteria by HAM. As expected, in murine peritoneal macrophages (MPM) IFN-gamma (2,500 U/ml) enhanced growth inhibition of BCC; the effect was abolished by the nitric oxide synthase (NOS) inhibitor NMMA. In contrast, IFN-gamma failed to enhance growth inhibition by HAM or PBM and NMMA had no effect. MPM expressed inducible nitric oxide synthase (NOS2) mRNA in response to LPS and IFN-gamma and produced NO. Neither NOS2 mRNA nor NO could be detected in HAM stimulated with LPS and IFN-gamma or mycobacteria. These data demonstrate that HAM, but not PBM or PMN, have NO-independent mycobacteriostatic activity in the early time period after infection with mycobacteria.
引用
收藏
页码:1943 / 1950
页数:8
相关论文
共 35 条
[1]   On the expression of nitric oxide synthase by human macrophages. Why no NO? [J].
Albina, JE .
JOURNAL OF LEUKOCYTE BIOLOGY, 1995, 58 (06) :643-649
[2]   KILLING OF VIRULENT MYCOBACTERIUM-TUBERCULOSIS BY REACTIVE NITROGEN INTERMEDIATES PRODUCED BY ACTIVATED MURINE MACROPHAGES [J].
CHAN, J ;
XING, Y ;
MAGLIOZZO, RS ;
BLOOM, BR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (04) :1111-1122
[3]   CHARACTERIZATION OF THE MYCOBACTERIUM-TUBERCULOSIS PHAGOSOME AND EVIDENCE THAT PHAGOSOMAL MATURATION IS INHIBITED [J].
CLEMENS, DL ;
HORWITZ, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) :257-270
[4]   MULTIPLE DEFECTS OF IMMUNE CELL-FUNCTION IN MICE WITH DISRUPTED INTERFERON-GAMMA GENES [J].
DALTON, DK ;
PITTSMEEK, S ;
KESHAV, S ;
FIGARI, IS ;
BRADLEY, A ;
STEWART, TA .
SCIENCE, 1993, 259 (5102) :1739-1742
[6]  
DING AH, 1988, J IMMUNOL, V141, P2407
[7]  
DOUVAS GS, 1986, AM REV RESPIR DIS, V134, P44
[8]   SURFACTANT PROTEIN-A PROMOTES ATTACHMENT OF MYCOBACTERIUM-TUBERCULOSIS TO ALVEOLAR MACROPHAGES DURING INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS [J].
DOWNING, JF ;
PASULA, R ;
WRIGHT, JR ;
TWIGG, HL ;
MARTIN, WJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :4848-4852
[10]  
DurrbaumLandmann I, 1996, INFECT IMMUN, V64, P5384